Source recordFED

Ormiston, Mark L

Federal grants & contributions· Canadian Institutes of Health Research· FY2018· $830,025· ON

Description

Cellular and molecular mechanisms of Natural Killer cell-mediated vascular remodeling in pulmonary arterial hypertension

Amendment chain · 1 entry

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.

$830,025$0Original · 2017-04-01 (start date) · total $830,025
  • #02017-04-01$830,025
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2017-04-01(start date)$830,025—Cellular and molecular mechanisms of Natural Killer cell-mediated vascular remodeling in pulmonary arterial hy…

Related records · 4

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (exact legal name match; no business number on file)

RefDepartment · programCurrent valueFY
236-2022-2023-Q4-00189Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research Investigator-Initiated Research$750,275FY2023
236-2021-2022-Q3-00794Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research$787,950FY2022
236-2016-2017-Q2-00090Canadian Institutes of Health Research | Instituts de recherche en santé du Canada$100,000FY2017
236-2015-2016-Q3-00033Canadian Institutes of Health Research | Instituts de recherche en santé du Canada$500,000FY2016

Cite as: Glassbox record view · Federal grants & contributions · 236-2017-2018-Q1-00560 · retrieved 2026-11-13.